The gut microbiota influences anticancer immunosurveillance and general health
The gut microbiota influences anticancer immunosurveillance and general healthThe gut microbiota influences anticancer immunosurveillance and general health, Published online: 10 April 2018; doi:10.1038/s41571-018-0006-2Emerging evidence indicates that the composition of the intestinal microbiota influences anticancer immunosurveillance and therefore the effectiveness of anticancer therapies, especially immune-checkpoint inhibitors. Herein, key contributors to this field of research discuss these connections between gut bacteria, anticancer immunity, and general health, with a focus on specific bacterial species consistently associated with favourable clinical outcomes of anticancer immunotherapy, and explore the potential mechanisms.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Bertrand Routy Vancheswaran Gopalakrishnan Romain Daill ère Laurence Zitvogel Jennifer A. Wargo Guido Kroemer Source Type: research
More News: Cancer & Oncology | Immunotherapy